Myenteric Plexus (Auerbach) Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The myenteric plexus, also known as Auerbach's plexus, is the major neural network controlling gastrointestinal motility. Located between the circular and longitudinal muscle layers of the enteric wall, it represents the largest collection of neurons outside the central nervous system and functions as a "second brain" capable of autonomous reflex control of gut function. Thisplexus plays critical roles in neurodegenerative diseases, particularly Parkinson's disease, where alpha-synuclein pathology frequently originates in enteric neurons before spreading to the central nervous system.
¶ Anatomy and Structure
The myenteric plexus forms a continuous sheet of neural ganglia extending from the esophagus to the internal anal sphincter. Key anatomical features include:
- Ganglion distribution: Approximately 3-5 ganglia per cm² in humans, with significant regional variation
- Neuronal composition: Estimates suggest 100-500 million neurons per adult human intestine
- Connective tissue: Enteric glial cells (EGCs) provide structural support and metabolic regulation
- Vascular supply: Rich capillary network supplying oxygen and nutrients to neuronal cell bodies
- Excitatory motor neurons: Release acetylcholine and substance P, driving circular muscle contraction
- Inhibitory motor neurons: Release nitric oxide (NO) and vasoactive intestinal peptide (VIP), promoting muscle relaxation
- Ascending interneurons: Transmit excitatory signals orally (procontractile)
- Descending interneurons: Transmit inhibitory signals anally (proinhibitory)
- Intrinsic primary afferent neurons (IPANs): Detect mucosal distortion, chemical changes, and tension
- Extrinsic afferents: Connect to vagal and spinal sensory pathways
¶ Neurotransmitters and Signaling
The myenteric plexus employs a diverse repertoire of neurotransmitters:
| Neurotransmitter |
Function |
| Acetylcholine (ACh) |
Primary excitatory motor neuron transmitter |
| Nitric oxide (NO) |
Primary inhibitory transmitter |
| Substance P |
Fast excitatory transmission |
| Vasoactive Intestinal Peptide (VIP) |
Slow inhibitory transmission |
| ATP |
Fast inhibitory transmission |
| 5-HT (Serotonin) |
Modulates motility and secretion |
Myenteric neurons exhibit characteristic electrophysiological properties:
- Resting membrane potential: -50 to -60 mV
- Action potential duration: 2-5 ms
- Firing patterns: Tonic, phasic, and burst firing depending on neuron type
- Synaptic potentials: Both fast (nicotinic) and slow (muscarinic) excitatory postsynaptic potentials
¶ Connectivity and Neural Circuits
The myenteric plexus integrates multiple reflex circuits:
- Peristaltic reflex: Distension triggers IPAN activation → ascending excitation → descending inhibition → coordinated propulsion
- Secretory reflex: Chemosensory detection triggers epithelial secretion via neural pathways
- Vasoactive reflexes: Local blood flow regulation in response to metabolic demands
The myenteric plexus is critically implicated in Parkinson's disease (PD) pathogenesis:
- Alpha-synuclein pathology: Lewy bodies containing phosphorylated alpha-synuclein are found in enteric neurons of PD patients, often years before motor symptoms
- Braak staging hypothesis: Suggests alpha-synuclein may originate in the gut and propagate via the vagus nerve to the brain
- GI dysfunction: Constipation is one of the earliest prodromal PD symptoms, reflecting enteric nervous system involvement
- Clinical implications: Biopsy of rectal or colonic submucosal neurons can detect alpha-synuclein for early PD diagnosis
- Amyloid-beta deposition: Enteric neurons can accumulate amyloid-beta plaques
- Cholinergic dysfunction: Loss of enteric cholinergic neurons may contribute to GI dysmotility in AD
- Gut-brain axis: Disrupted intestinal barrier (leaky gut) may promote neuroinflammation
- Multiple System Atrophy (MSA): Alpha-synuclein pathology in enteric neurons
- Dementia with Lewy Bodies: Similar enteric involvement as PD
- Amyotrophic Lateral Sclerosis (ALS): GI dysmotility reported in some patients
- Early PD detection: Rectal biopsy for alpha-synuclein immunohistochemistry
- Autonomic testing: Assessment of enteric nervous system function
- Transit studies: Evaluation of GI motility disorders
- Gut-targeted interventions: Probiotics, fecal microbiota transplantation
- Enteric neuroprotection: Research on preventing alpha-synuclein aggregation
- Drug delivery: Leveraging the gut-brain axis for CNS therapeutics
| Condition |
Myenteric Plexus Involvement |
| Parkinson's Disease |
Alpha-synuclein pathology, Lewy bodies |
| Hirschsprung Disease |
Congenital aganglionosis |
| Chronic Intestinal Pseudo-Obstruction |
Enteric ganglionitis |
| Irritable Bowel Syndrome |
Visceral hypersensitivity |
| Diabetic Enteropathy |
Autonomic neuropathy |
Key approaches to studying the myenteric plexus include:
- Whole-mount immunohistochemistry: Visualization of neuronal networks
- Electrophysiology: Intracellular and extracellular recording
- Calcium imaging: Functional neuronal activity mapping
- Single-cell RNA sequencing: Molecular characterization of enteric neuron subtypes
- Organoid systems: Patient-derived intestinal models
Promising therapeutic approaches include:
- Alpha-synuclein aggregation inhibitors: Preventing Lewy body formation in enteric neurons
- Neurotrophic factors: GDNF, BDNF to support enteric neuron survival
- Microbiome modulation: Targeting gut microbiota to reduce neurodegeneration
- Anti-inflammatory agents: Addressing neuroinflammation in the gut-brain axis
- Stem cell therapy: Replacing lost enteric neurons
Myenteric Plexus (Auerbach) Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Myenteric Plexus (Auerbach) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Furness JB (2012). The enteric nervous system and neurogastroenterology. Nature Reviews Gastroenterology & Hepatology, 9(5), 286-294.
- Braak H, et al. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging, 24(2), 197-211.
- Shannon KM, et al. (2005). Alpha-synuclein in gastric and esophageal enteric neurons: Implications for Parkinson's disease. Movement Disorders, 20(7), 791-793.
- Giancola F, et al. (2017). Enteric alpha-synuclein expression is increased in Parkinson's disease but not in Alzheimer's disease. Movement Disorders, 32(10), 1403-1412.
- Clairembault T, et al. (2015). Enteric alpha-synuclein expression is increased in non-demented elderly patients with Parkinson's disease. Neurobiology of Aging, 36(7), 2265.e1-2265.e8.
- Holmqvist S, et al. (2014). Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathologica, 128(6), 805-820.
- Rao M, Gershon MD (2016). The bowel and beyond: The enteric nervous system in neurological disorders. Nature Reviews Gastroenterology & Hepatology, 13(9), 517-528.
- Furness JB, et al. (2014). Novel technologies for the study of the enteric nervous system. Neurogastroenterology & Motility, 26(7), 905-917.